10-93593825-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_006744.4(RBP4):c.566A>G(p.Asn189Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,459,328 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 18/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. N189N) has been classified as Uncertain significance.
Frequency
Consequence
NM_006744.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RBP4 | NM_006744.4 | c.566A>G | p.Asn189Ser | missense_variant, splice_region_variant | 5/6 | ENST00000371464.8 | |
RBP4 | NM_001323517.1 | c.566A>G | p.Asn189Ser | missense_variant, splice_region_variant | 5/6 | ||
RBP4 | NM_001323518.2 | c.560A>G | p.Asn187Ser | missense_variant, splice_region_variant | 5/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RBP4 | ENST00000371464.8 | c.566A>G | p.Asn189Ser | missense_variant, splice_region_variant | 5/6 | 1 | NM_006744.4 | P1 | |
RBP4 | ENST00000371467.5 | c.566A>G | p.Asn189Ser | missense_variant, splice_region_variant | 5/6 | 5 | P1 | ||
RBP4 | ENST00000371469.2 | c.560A>G | p.Asn187Ser | missense_variant, splice_region_variant | 5/6 | 5 | |||
FFAR4 | ENST00000604414.1 | c.697-10249T>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250596Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135516
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1459328Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726018
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.566A>G (p.N189S) alteration is located in exon 5 (coding exon 4) of the RBP4 gene. This alteration results from a A to G substitution at nucleotide position 566, causing the asparagine (N) at amino acid position 189 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2023 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 189 of the RBP4 protein (p.Asn189Ser). This variant is present in population databases (rs750356617, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with RBP4-related conditions. ClinVar contains an entry for this variant (Variation ID: 839508). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at